Biotricity Stock Performance
| BTCY Stock | USD 0.29 0.01 4.92% |
The firm shows a Beta (market volatility) of 0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Biotricity's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotricity is expected to be smaller as well. At this point, Biotricity has a negative expected return of -0.56%. Please make sure to confirm Biotricity's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Biotricity performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Biotricity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:6 | Last Split Date 2023-07-03 |
1 | Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th | 11/07/2025 |
2 | Biotricity Inc. Reports Q2 Loss, Lags Revenue Estimates | 11/14/2025 |
3 | Biotricity, Inc. Q2 2026 Earnings Call Transcript | 11/18/2025 |
4 | Acquisition by John Ayanoglou of 50000 shares of Biotricity at 2.4 subject to Rule 16b-3 | 12/19/2025 |
Biotricity | Build AI portfolio with Biotricity Stock |
Biotricity Relative Risk vs. Return Landscape
If you would invest 52.00 in Biotricity on October 8, 2025 and sell it today you would lose (22.00) from holding Biotricity or give up 42.31% of portfolio value over 90 days. Biotricity is currently does not generate positive expected returns and assumes 8.5157% risk (volatility on return distribution) over the 90 days horizon. In different words, 76% of stocks are less volatile than Biotricity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biotricity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotricity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biotricity, and traders can use it to determine the average amount a Biotricity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0657
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BTCY |
Based on monthly moving average Biotricity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotricity by adding Biotricity to a well-diversified portfolio.
Biotricity Fundamentals Growth
Biotricity Stock prices reflect investors' perceptions of the future prospects and financial health of Biotricity, and Biotricity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotricity Stock performance.
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.37) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 36.14 M | ||||
| Shares Outstanding | 26.57 M | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 33.02 X | ||||
| Price To Sales | 0.53 X | ||||
| Revenue | 13.79 M | ||||
| Gross Profit | 11.32 M | ||||
| EBITDA | (3.21 M) | ||||
| Net Income | (8.42 M) | ||||
| Cash And Equivalents | 2.89 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 26.09 M | ||||
| Debt To Equity | 6.45 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | (1.23) X | ||||
| Cash Flow From Operations | (2.38 M) | ||||
| Earnings Per Share | (0.09) X | ||||
| Market Capitalization | 14.17 M | ||||
| Total Asset | 5.64 M | ||||
| Retained Earnings | (139.44 M) | ||||
| Working Capital | (16 M) | ||||
| Current Asset | 11 K | ||||
| Current Liabilities | 303 K | ||||
About Biotricity Performance
Evaluating Biotricity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Biotricity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biotricity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 158.39 | 88.16 | |
| Return On Tangible Assets | (9.99) | (10.49) | |
| Return On Capital Employed | 4.14 | 4.35 | |
| Return On Assets | (9.99) | (10.49) | |
| Return On Equity | 4.18 | 4.39 |
Things to note about Biotricity performance evaluation
Checking the ongoing alerts about Biotricity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biotricity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotricity generated a negative expected return over the last 90 days | |
| Biotricity has high historical volatility and very poor performance | |
| Biotricity has some characteristics of a very speculative penny stock | |
| Biotricity has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 13.79 M. Net Loss for the year was (8.42 M) with profit before overhead, payroll, taxes, and interest of 11.32 M. | |
| Biotricity currently holds about 2.89 M in cash with (2.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Biotricity has a poor financial position based on the latest SEC disclosures | |
| Roughly 39.0% of the company shares are held by company insiders |
- Analyzing Biotricity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotricity's stock is overvalued or undervalued compared to its peers.
- Examining Biotricity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotricity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotricity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biotricity's stock. These opinions can provide insight into Biotricity's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Biotricity Stock Analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.